# A Trial to Investigate Scar Improvement Efficacy of RN1001 (Avotermin) After Head and Neck Naevi Excision

> **NCT00656227** · PHASE2 · UNKNOWN · sponsor: **Renovo** · enrollment: 239 (actual)

## Conditions studied

- Nevus
- Cicatrix

## Interventions

- **DRUG:** Avotermin

## Key facts

- **NCT ID:** NCT00656227
- **Lead sponsor:** Renovo
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2004-04
- **Primary completion:** 2007-07
- **Final completion:** 2012-07
- **Target enrollment:** 239 (ACTUAL)
- **Last updated:** 2008-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00656227

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00656227, "A Trial to Investigate Scar Improvement Efficacy of RN1001 (Avotermin) After Head and Neck Naevi Excision". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT00656227. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*